147 related articles for article (PubMed ID: 29390436)
1. Endostar combined with chemotherapy in a pediatric osteosarcoma with pulmonary metastasis and malignant pleural effusion: A case report.
Jiang S; Wang G; Dong Y
Medicine (Baltimore); 2017 Dec; 96(51):e9077. PubMed ID: 29390436
[TBL] [Abstract][Full Text] [Related]
2. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
3. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis.
Biaoxue R; Xiguang C; Hua L; Wenlong G; Shuanying Y
BMC Cancer; 2016 Nov; 16(1):888. PubMed ID: 27842514
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
Hu Y; Zhou Z; Luo M
Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
[TBL] [Abstract][Full Text] [Related]
5. Long-term survival in high-grade axial osteosarcoma with bone and lung metastases treated with chemotherapy only.
del Prever AB; Fagioli F; Berta M; Bertoni F; Ferrari S; Mercuri M
J Pediatr Hematol Oncol; 2005 Jan; 27(1):42-5. PubMed ID: 15654278
[TBL] [Abstract][Full Text] [Related]
6. Osteosarcoma of the extremities with synchronous lung metastases: long-term results in 44 patients treated with neoadjuvant chemotherapy.
Bacci G; Briccoli A; Mercuri M; Ferrari S; Bertoni F; Gasbarrini A; Fabbri N; Cesari M; Forni C; Campanacci M
J Chemother; 1998 Feb; 10(1):69-76. PubMed ID: 9531078
[TBL] [Abstract][Full Text] [Related]
7. [An autopsy case of pulmonary and central nervous system metastatic osteosarcoma treated with thirty-six courses of chemotherapy over four years].
Ito T; Mochida A; Saito K; Nishi K; Sasaki S; Hisada T; Morinari H; Nakahara K; Tahara M; Masuda S; Yakumaru K
Nihon Kokyuki Gakkai Zasshi; 2002 Jan; 40(1):71-6. PubMed ID: 11925923
[TBL] [Abstract][Full Text] [Related]
8. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
9. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
Zhao WY; Chen DY; Chen JH; Ji ZN
Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis].
Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ
Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058
[No Abstract] [Full Text] [Related]
11. Recombinant human endostatin (endostar) decreased recurrent ascites, pleural fluid and ascitic VEGF in a case of advanced mesothelioma.
Chen X; Liu Y; Yin Y; Jin S; Ping G; Røe OD; Yan K; Shu Y; Guo R
J Chemother; 2012 Aug; 24(4):231-6. PubMed ID: 23040690
[TBL] [Abstract][Full Text] [Related]
12. [Organ-preserving interventions in combined therapy of children and adolescents with osteosarcoma].
Punanov IuA; Gafton GI; Gudz' IuV; Nabokov VV; Ivanova TV; Safonova SA; Levchenko EV; Kupatadze DD; Novik VI; Lazareva IuR; Krzhivitskiĭ PI; Petrov VG
Vopr Onkol; 2012; 58(2):275-81. PubMed ID: 22774537
[TBL] [Abstract][Full Text] [Related]
13. Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
Goorin AM; Harris MB; Bernstein M; Ferguson W; Devidas M; Siegal GP; Gebhardt MC; Schwartz CL; Link M; Grier HE
J Clin Oncol; 2002 Jan; 20(2):426-33. PubMed ID: 11786570
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of relapsed osteosarcoma. Role of chemotherapy using ifosamide and carboplatin].
Machak GN; Polotskiĭ BE; Meluzova OM; Chernov IS; Aliev MD
Vopr Onkol; 2010; 56(2):220-5. PubMed ID: 20552902
[TBL] [Abstract][Full Text] [Related]
15. [Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
Fujita H; Kiyokawa N; Takada K; Kyo K; Ishimoto K; Yabuta K; Mizuno T
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2167-70. PubMed ID: 1888188
[TBL] [Abstract][Full Text] [Related]
16. Successful management of a widespread osteosarcoma. A case report.
Grohn P; Uttamchandani A; Al-Haider Z; Adams B
Med Princ Pract; 2004; 13(1):54-6. PubMed ID: 14657622
[TBL] [Abstract][Full Text] [Related]
17. Prevention of postoperative progression of pulmonary metastases in osteosarcoma by antiangiogenic therapy using endostatin.
Kaya M; Wada T; Nagoya S; Yamashita T
J Orthop Sci; 2007 Nov; 12(6):562-7. PubMed ID: 18040639
[TBL] [Abstract][Full Text] [Related]
18. Osteogenic sarcoma of the extremity with detectable lung metastases at presentation. Results of treatment of 23 patients with chemotherapy followed by simultaneous resection of primary and metastatic lesions.
Bacci G; Mercuri M; Briccoli A; Ferrari S; Bertoni F; Donati D; Monti C; Zanoni A; Forni C; Manfrini M
Cancer; 1997 Jan; 79(2):245-54. PubMed ID: 9010097
[TBL] [Abstract][Full Text] [Related]
19. Recombined humanized endostatin (Endostar) combined with chemotherapy for advanced bone and soft tissue sarcomas in stage IV.
Xing P; Zhang J; Yan Z; Zhao G; Li X; Wang G; Yang Y; Zhao J; Xing R; Teng S; Ma Y; Liao Z; Ren Z; Zhang C; Han X; Zhang W; Chen K; Wang P; Yang J
Oncotarget; 2017 May; 8(22):36716-36727. PubMed ID: 27888623
[TBL] [Abstract][Full Text] [Related]
20. Effect of thoracic hyperthermic perfusion with recombinant human endostatin plus nedaplatin in treating pleural effusion in patients with advanced non-small cell lung cancer.
Chen L; Zhu X; Li D; Cai X
J BUON; 2020; 25(6):2643-2649. PubMed ID: 33455108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
